Charlie Albright | Chief Scientific Officer
Editas Medicine

Charlie Albright, Chief Scientific Officer, Editas Medicine

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 11:50

Further defining the path to the clinic for in vivo gene editing

last published: 24/Mar/19 01:45 GMT

back to speakers